Table S2 from Reprogramming CAR with Cytokine Signaling Increases the Efficacy of CAR T-cell Therapy in Solid Tumor Treatment and Confers Sustained Immune Memory
Rongchen Sun, Shang Liu, Xue Yang, Changshuai Che et autres
Table S2
0 citations
Xue Yang
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
10Publications signalées
1Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Immunotherapy and Immune ResponsesVirus-based gene therapy researchCAR-T cell therapy research
Les publications récentes
Figure S1 from Reprogramming CAR with Cytokine Signaling Increases the Efficacy of CAR T-cell Therapy in Solid Tumor Treatment and Confers Sustained Immune Memory
Rongchen Sun, Shang Liu, Xue Yang, Changshuai Che et autres
Figure S1
0 citations
Table S1 from Reprogramming CAR with Cytokine Signaling Increases the Efficacy of CAR T-cell Therapy in Solid Tumor Treatment and Confers Sustained Immune Memory
Rongchen Sun, Shang Liu, Xue Yang, Changshuai Che et autres
Table S1
0 citations
Figure S2 from Reprogramming CAR with Cytokine Signaling Increases the Efficacy of CAR T-cell Therapy in Solid Tumor Treatment and Confers Sustained Immune Memory
Rongchen Sun, Shang Liu, Xue Yang, Changshuai Che et autres
Figure S2
0 citations
Figure S5 from Reprogramming CAR with Cytokine Signaling Increases the Efficacy of CAR T-cell Therapy in Solid Tumor Treatment and Confers Sustained Immune Memory
Rongchen Sun, Shang Liu, Xue Yang, Changshuai Che et autres
Figure S5
0 citations
Data from Reprogramming CAR with Cytokine Signaling Increases the Efficacy of CAR T-cell Therapy in Solid Tumor Treatment and Confers Sustained Immune Memory
Rongchen Sun, Shang Liu, Xue Yang, Changshuai Che et autres
Abstract Chimeric antigen receptor (CAR) T-cell therapy has shown remarkable efficacy in hematologic malignancies but remains limited in solid tumors because of the immunosuppressive microenvironment, tumor heterogeneity, poor immune cell infiltration, and progressive T-cell dysfunction. Because cytokine costimulation is critical for maintaining …
0 citations
Figure S4 from Reprogramming CAR with Cytokine Signaling Increases the Efficacy of CAR T-cell Therapy in Solid Tumor Treatment and Confers Sustained Immune Memory
Rongchen Sun, Shang Liu, Xue Yang, Changshuai Che et autres
Figure S4
0 citations
Figure S3 from Reprogramming CAR with Cytokine Signaling Increases the Efficacy of CAR T-cell Therapy in Solid Tumor Treatment and Confers Sustained Immune Memory
Rongchen Sun, Shang Liu, Xue Yang, Changshuai Che et autres
Figure S3
0 citations
Table S3 from Reprogramming CAR with Cytokine Signaling Increases the Efficacy of CAR T-cell Therapy in Solid Tumor Treatment and Confers Sustained Immune Memory
Rongchen Sun, Shang Liu, Xue Yang, Changshuai Che et autres
Table S3
0 citations
Reprogramming CAR with Cytokine Signaling Increases the Efficacy of CAR T-cell Therapy in Solid Tumor Treatment and Confers Sustained Immune Memory
Rongchen Sun, Shang Liu, Xue Yang, Changshuai Che et autres
Chimeric antigen receptor (CAR) T-cell therapy has shown remarkable efficacy in hematologic malignancies but remains limited in solid tumors because of the immunosuppressive microenvironment, tumor heterogeneity, poor immune cell infiltration, and progressive T-cell dysfunction. Because cytokine costimulation is critical for maintaining T-cell …
cn (code pays fourni par la source)
1 citation
Cancer Immunology Research
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.